Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,981.00
Bid: 1,985.00
Ask: 1,987.00
Change: 8.00 (0.41%)
Spread: 2.00 (0.101%)
Open: 1,967.00
High: 1,989.00
Low: 1,966.00
Prev. Close: 1,973.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Shire Gains As Takeover By AbbVie Confirmed

Fri, 18th Jul 2014 10:59

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday.
-------
FTSE 100 - WINNERS
-------
Shire, up 1.6%. Following weeks of speculation that has seen Shire gain about 40% in value, US suitor AbbVie has confirmed that the two companies have agreed on a takeover deal that values Shire at about GBP32 billion. The agreement will give Shire shareholders GBP24.44 in cash and 0.8960 of an AbbVie share for each Shire share. The agreement comes after a series of proposals from AbbVie, which Shire rebuffed on three separate occasions. The agreement is the latest of a number of "tax inversion" deals that has seen US companied re-domicile abroad to take advantage of lower corporate tax rates.

Severn Trent, up 0.9%. The water company is seeing a rebound after falling amid a wider equity sell-off Thursday that saw it lose 1.7%. In a statement Thursday, management said it has been trading in line with expectations in recent months.

British Land, up 0.4%. Barclays upgraded its price target on the real estate investment company by 35%, to 936 pence from 695 pence. The bank said it expects the British Land to outperform as the value of its underlying real estate values continue to increase.
-------
FTSE 100 - LOSERS
-------
Barratt Developments, down 2.6%. The housebuilder suffered a downgrade to Hold from Buy by Liberum Capital Friday. In a note on the whole sector, Liberum was positive about the outlook for the housebuilders over the coming year, saying that the market has been overestimating the risk of a near-term UK interest rate rise and that mortgage lending should begin to rise again. Even so, the brokerage lowered its price targets on most of the stocks in the sector to take account of recent weakness and said it has concerns over Barratt Development's relative valuation.

UK Banks: RBS, down 2.0%; Lloyds, down 0.9%; HSBC, down 0.7%; Barclays, down 0.2%. The banking sector is under pressure after the UK Competition Markets Authority recommended an in-depth market investigation into the retail banking sector, saying that essential parts of it do not meet the needs of its customers. The big four banks account for more than 75% of all UK current accounts and, in a worst case scenario for the banks, the CMA could recommend that they are broken-up to increase competition from smaller financial service providers.
-------
FTSE 250 WINNERS
-------
Carphone Warehouse, up 3.3%; Dixons Retail, up 2.3%. The shareholders of the two retailers voted overwhelmingly in favour of their proposed merger at their separate annual general meetings on Thursday. The deal will create a new giant of the UK high street, Dixons Carphone, which will own 1,298 stores in the UK, and almost 3,000 worldwide.

Hikma Pharmaceuticals, up 1.3%. Goldman Sachs upgraded the stock to Buy from Neutral, and also increased its price target by 20% to 2,250 pence from 1,800 pence
-------
AIM All-Share WINNERS
-------
Anglo Asian Mining, up 15%. The gold producer with operations in Azerbaijan said gold production for its second quarter ended June 30 increased 39% on the previous quarter and 77% on the previous year to 15,736 ounces, with the vast majority coming from its agitation leaching plant at the Gedabek project. The company also increased its copper production target due to strong production from its sulphidisation, acidification, recycling, and thickening (SART) processing operations.
-------
AIM All-Share LOSERS
-------
Ducat Ventures, down 29%. The investment company proposed the purchase of OptiBiotix Health Ltd, in a reverse takeover that will turn the investing company into a food science business to be called OptiBiotix Health PLC. In a statement, Ducat Ventures said that its broker, Peterhouse Corporate Finance Ltd, also has conditionally raised an additional GBP3.3 million before expenses for the company by placing 41.3 million new shares at 8 pence each. The net proceeds of the second issuance, estimated at GBP2.8 million, will be used to develop OptiBiotix products and for general working capital purposes.

PhotonStar LED Group, down 10%. The designer and manufacturer of smart LED lighting solutions said it has conditionally raised around GBP2.2 million through a placing of 31.4 million new shares at a price of 7 pence per share. The company said it will use the proceeds of the placing to maximise the commercial opportunities of its Halcyon system. Halcyon is a wireless retrofit lighting system that includes sensors and is controlled wirelessly by a powerful, low cost server.
-------
By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.